rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Pasithea Therapeutics Corp.

KTTA · Nasdaq

Health CareBiotechnologyNot moving yet

KTTA stood above a rising 150-day average in 8 of the last 52 weekly readings, and has been out of that trend for the last 31 weeks. It is 30.7% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 31
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$256K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
24 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 8 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$145KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months0
Buyers · sellers4 · 0
WhoDidSharesTraded
Coastlands Capital Lp10% ownerbought100,000at $0.5317 Jun 2026filed 22 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders24+4 on the quarter
New · exited5 · 1
Reported value$8.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Cable Car Capital, LPadded · filed 14 Aug 20263,000,000$1.5M+1,793,621+148.7%
Stonepine Capital Management, LLCadded · filed 14 Aug 20262,201,468$1.1M+1,370,167+164.8%
ADAGE CAPITAL PARTNERS GP, L.L.C.unchanged · filed 14 Aug 20262,100,000$1.1M00.0%
Jupiter Topco LLCnew · filed 14 Aug 20262,100,000$1.1M+2,100,000
Opaleye Management Inc.new · filed 14 Aug 20262,050,000$1.1M+2,050,000
AMERIPRISE FINANCIAL INCadded · filed 14 Aug 20261,864,485$961K+513,589+38.0%
Squadron Capital Management LLCreduced · filed 14 Aug 20261,000,000$515K-1,100,000−52.4%
AdvisorShares Investments LLCadded · filed 11 Aug 2026937,550$483K+600,042+177.8%
Vivo Capital, LLCreduced · filed 14 Aug 2026465,471$240K-1,634,529−77.8%
Persistent Asset Partners Ltdunchanged · filed 7 Aug 2026290,555$150K00.0%
31 Mar 2024 – 30 Jun 2026
71523Mar 24Sep 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Coastlands Capital LP Company insider10% owner · last 17 Jun 20261 · 0
Alfred J. Novak Company insiderDirector · last 1 May 20260 · 0
Daniel H. Schneiderman Company insiderChief Financial Officer · last 1 May 20260 · 0
Emer Leahy Company insiderDirector · last 1 May 20260 · 0
Kartik Krishnan Company insiderChief Medical Officer · last 1 May 20260 · 0
Lawrence Steinman Company insiderDirector · last 1 May 20262 · 0
Simon Dumesnil Company insiderDirector · last 1 May 20261 · 0
Tiago Marques Company insiderChief Executive Officer · last 1 May 20261 · 1
Graeme Martin Currie Company insiderChief Development Officer · last 1 Mar 20240 · 0
David Delaney Company insiderOther · last 17 Oct 20221 · 0
Camac Fund, Lp Company insiderOther · last 29 Sep 20226 · 0
Camac Capital, Llc Company insiderOther · last 30 Aug 20222 · 0

Same industry

MRNA ModernaLeading+167%
ENTX Entera BioLeading+52%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-37.7%
Share count trendFY 2025 · to 24 Mar 20268.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$55.2M

Analyst forecasts

No analyst forecasts yet.